Francès C
Groupe hospitalier Pitié-Salpêtrière, Paris.
Rev Prat. 1990 Feb 21;40(6):527-30.
Topical corticosteroids are mainly used for their anti-inflammatory activity by a complex mechanism Which involves vasoconstriction, inhibition of leucocyte migration and stabilization of lysosomal membranes with inhibition of inflammation factors synthesis. In non-inflammatory skin diseases, they are used for their antimitotic effect or their ability to inhibit the synthesis of several macromolecules forming the connective tissue. So many topical corticosteroids are now available that they must be classified according to their level of activity, as measured by a vasoconstriction test. The European classification system has four levels numbered I to IV in descending order of potency. The choice of activity level depends on the patient's age and on the location, extent and acute or chronic character of the lesions. Creams are the most versatile preparations. Topical corticosteroids are contra-indicated in all infective skin diseases. Penetration through the skin varies according to the corticosteroid utilized, to the state of the skin on which it is applied and to the modalities of its applications. Irreversible skin atrophy is usually observed only after prolonged use of topical steroids levels I and II.
外用皮质类固醇主要通过一种复杂机制发挥其抗炎活性,该机制涉及血管收缩、抑制白细胞迁移以及稳定溶酶体膜并抑制炎症因子合成。在非炎症性皮肤病中,它们因其抗有丝分裂作用或抑制构成结缔组织的几种大分子合成的能力而被使用。现在有许多外用皮质类固醇,必须根据通过血管收缩试验测定的活性水平进行分类。欧洲分类系统有四个级别,按效力从高到低依次编号为I至IV。活性水平的选择取决于患者的年龄以及皮损的部位、范围和急性或慢性特征。乳膏是用途最广泛的制剂。外用皮质类固醇在所有感染性皮肤病中均为禁忌。其透过皮肤的情况因所使用的皮质类固醇、涂抹部位的皮肤状态以及应用方式而异。通常仅在长期使用I级和II级外用类固醇后才会观察到不可逆的皮肤萎缩。